Location History:
- Castelveccana, IT (2021 - 2023)
- Castelvaccana, IT (2023)
Company Filing History:
Years Active: 2021-2025
Title: Innovations by Paolo Barassi in Heart Failure Treatment
Introduction
Paolo Barassi is a notable inventor based in Castelveccana, Italy, recognized for his contributions to medical innovations, particularly in the treatment of heart failure. With a total of four patents to his name, Barassi has made significant strides in developing formulations and compounds aimed at improving cardiac health.
Latest Patents
Barassi's latest patents include an intravenous formulation containing istaroxime for the treatment of acute heart failure (AHF). This patent discloses compositions for intravenous infusion of istaroxime or its metabolites in patients suffering from heart failure. The methods described involve extended infusion periods exceeding six hours to enhance cardiac relaxation while minimizing the risk of arrhythmogenic events. Additionally, Barassi has developed 17beta-heterocyclyl-digitalis-like compounds aimed at treating both acute and chronic heart failure. These compounds are characterized by specific structural formulas and are intended for use as medicaments, with options for oral administration as well.
Career Highlights
Throughout his career, Barassi has worked with various companies, including Windtree Therapeutics, Inc. and Cvie Therapeutics Limited. His work in these organizations has contributed to the advancement of therapeutic options for heart failure patients.
Collaborations
Barassi has collaborated with notable colleagues such as Giuseppe Bianchi and Patrizia Ferrari, further enhancing the impact of his innovations in the medical field.
Conclusion
Paolo Barassi's innovative work in the field of heart failure treatment showcases his dedication to improving patient outcomes through advanced medical formulations and compounds. His contributions continue to influence the landscape of cardiac care.